Epidarex Capital

Summary

Epidarex Capital appeared to be the VC, which was created in 2010. The company was established in North America in United States. The main office of represented VC is situated in the Bethesda.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Epidarex Capital, startups are often financed by Mercury Fund, Kei Aar, Imperial Innovations. The meaningful sponsors for the fund in investment in the same round are Scottish Investment Bank, venBio Partners, Imperial Innovations. In the next rounds fund is usually obtained by Pitch@Palace, Innovate UK, Imperial Innovations.

We also calculated 4 valuable employees in our database.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Clyde Biosciences, Sirakoss, Mironid. For fund there is no match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most successful fund investment fields, there are Medical, Health Diagnostics. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. The higher amount of exits for fund were in 2017. The real fund results show that this VC is 40 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Epidarex Capital performs on 19 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars.